Foghorn Therapeutics Inc is a biotechnology company that specializes in the development of treatments for cancer and other genetic diseases by focusing on the modulation of gene expression
The company leverages its proprietary Gene Traffic Control platform to create small molecule therapies that specifically target the proteins involved in gene regulation, with the aim of providing more effective and personalized treatment options. By understanding and manipulating the underlying mechanisms of gene activity, Foghorn seeks to address unmet medical needs and improve patient outcomes in challenging therapeutic areas.
Foghorn Therapeutics shares are trading lower by 20.2% during Monday's session. The company announced it will discontinue independent development of its FHD-286 program.
Gainers Addentax Group Corp. (NASDAQATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
Keybanc boosted the price target for Micron Technology, Inc. (NASDAQMU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading.
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 40 points on Monday. The Dow traded up 0.05% to 33,827.42 while the NASDAQ fell 0.33% to 12,032.16. The S&P 500, also fell, dropping, 0.01% to 4,132.91.
U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping around 100 points on Monday. The Dow traded down 0.19% to 33,744.92 while the NASDAQ fell 0.84% to 11,971. The S&P 500, also fell, dropping, 0.32% to 4,120.38.
